Medical & Pharmaceuticals

Preparing the Development Safety Update Report

The CIOMS VII Working Group is proposing an internationally harmonised document, the Development Safety Update Report (DSUR) to streamline the process by which drug trial safety is monitored, which should improve patient safety, especially during a time when the effectiveness of a treatment is uncertain. The reason behind this is due to the fact that even though regulatory authorities in ... Read More »

Social Media: Our Past Present and the Future of Digital Health Online

SMi Group’s CPD accredited Social Media: Our Past, Present and the Future of Digital Health Online masterclass provides industry professionals with the tools needed to plan, execute and fully incorporate social media as part of your pharmaceutical firm’s effective overall online digital strategy.   Social media’s potential as a tool to raise awareness in healthcare issues has become a ‘hot’ ... Read More »

New Pharmaceutical Marketing and Strategy in Opinion Leadership

Massive changes have occurred over the last decade in the pharmaceutical industry and have consequently led to a period of transition, which has necessitated a change in approach. The previous blockbuster model was showing cracks, and reps were no longer seen as the solution to a lot of problems. SMi’s CPD accredited Masterclass gives industry professionals an insight into the ... Read More »

Intellectual Property and Licensing in Biotech

For biotech ideas to be successful, the idea must be protected by an IP strategy that supports financing and partnering and that results in an IP portfolio that provides sufficient exclusivity to ensure a good return on investment. SMi Group provides a CPD accredited masterclass which helps delegates and their firms ensure IP success by enabling professionals to discuss the ... Read More »

Patent Issues in the Development of Biosimilar Medicines

Biosimilar medicines are already a commercial reality in the European Union.  The U.S. Healthcare Reform legislation – with its defined pathway for the regulatory approval of follow-on biologics – should open up the U.S. market in the future, but in the meantime, the next batch of biosimilars will face other difficulties in reaching the market, both in the EU and ... Read More »

Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) Receives First Order for the Chinese Marketplace

CENTERVILLE, MA – June 7, 2011 (Investorideas.com Newswire) – UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) announced today that it had received its first order of ViraTech UV-400′s for test and evaluation for the Chinese marketplace. The units will be manufactured to Chinese electrical standards, and will be shipped for evaluation to 3 hospitals in different Chinese cities. “This ... Read More »

Pharma News; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) To Present at Jefferies Global Healthcare Conference

LINCOLNSHIRE, Ill. – June 7, 2011 (Investorideas.com newswire) – BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Phillip B. Donenberg, BioSante’s senior vice president of finance and CFO, will speak on Thursday, June 9, 2011 at 4:00pm eastern time at the Jefferies 2011 Global Healthcare Conference at the Grand Hyatt Hotel in New York City. Mr. Donenberg will provide an overview ... Read More »

Healthquest Offers MUA (Manipulation under Anesthesia), a Highly Effective, Non -invasive Pain Management Technique

Non-Invasive and Specialized Chronic Pain Treatment HealthQuest, a reputable multi-specialty healthcare center based in Brooklyn, New York City (NYC), offers MUA (Manipulation Under anesthesia), a non-invasive, highly specialized treatment for chronic pain sufferers who have not responded to long-term conservative care. The procedure is very effective for the treatment of fibroblastic proliferative changes, failed back syndromes, recurrent and chronic back ... Read More »

Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) Introduces “RX Air Plus,” One of the World’s Most Advanced Air Purification Systems

CENTERVILLE, MA � June 6, 2011 (Investorideas.com Newswire) – UV Flu Technologies, Inc. (OTCBB: UVFT) (the “Company”) is pleased to announce it has commenced marketing the “RX Air Plus” Air Purification System, which the Company believes could revolutionize the air purification marketplace. The new system may prove to be the most effective air purification system in the world today, as ... Read More »

HIV Cure Needs More Commitment and Money

Though there are many scientists working towards finding a cure for HIV, nobody was successful. The “International Workshop on HIV reservoirs and Eradication Strategies” has been formed in 2003 only to find a solution to the issue of HIV persistence. Tucker, GA, June 04, 2011 — For 3 decades now HIV has created jitters everywhere. The number of HIV cases ... Read More »